Study Makes New Tamoxifen Recommendations For Breast Cancer Patients

A new study finds that breast cancer patients who take the drug Tamoxifen can cut their chances of a recurrence if they stay on the pills for 10 years instead of five years, as doctors recommend now; KDKA's Dr. Maria Simbra reports.